Company family
Almus: medicine shortages
As of 2 Nov 2026, 18 Almus products have a reported shortage across 2 countries, covering 11 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Doxazosin | 2 | 27 May 2026 | Manufacturing problem | 5/16 | |
| Duloxetine | 2 | 17 Nov 2025 | Manufacturing problem | 12/16 | |
| Levetiracetam | 2 | 21 Sep 2026 | Manufacturing problem | 9/16 | |
| Levofloxacin | 2 | 21 Jul 2026 | Not stated | 4/16 | |
| Sertraline | 2 | 31 Aug 2024 | Manufacturing problem | 11/16 | |
| Simvastatin and Ezetimibe | 2 | 2 Mar 2026 | Manufacturing problem | 8/16 | |
| Tadalafil | 2 | 31 Mar 2026 | Manufacturing problem | 10/16 | |
| Clarithromycin | 1 | 24 Apr 2026 | Manufacturing problem | 5/16 | |
| Clopidogrel | 1 | 1 Dec 2026 | Manufacturing problem | 9/16 | |
| Diclofenac | 1 | 1 Oct 2025 | Manufacturing problem | 10/16 | |
| Tamsulosin | 1 | 1 Jul 2025 | Manufacturing problem | 6/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.